Aikya Investment Management Ltd
An institutional investment manager in LONDON. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 12, 2026. SEC CIK 2005403.
- Reported value$340.6m
- Positions5
Holdings: 5 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Dr. Reddy's Laboratories LimitedRDY | ADR | 256135203 | 123 | 36.1% | 8,493,852 | Added+494,056 | |
| EPAM Systems IncEPAM | Common Stock | 29414B104 | 108 | 31.8% | 1,365,913 | Added+455,298 | |
| HDFC Bank LimitedHDB | ADR | 40415F101 | 105 | 31.0% | 4,081,592 | Reduced−41,935 | |
| Infosys LtdINFY | ADR | 456788108 | 3.7 | 1.1% | 352,907 | Reduced−243,439 | |
| MakeMyTrip LTD | Common Stock | V5633W109 | 0.0 | <0.1% | 525 | New+525 |
Source: SEC EDGAR, Form 13F-HR, accession 0002005403-26-000004 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.